AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Sitascore-M 500/50 Tablet

Prescription Icon
Prescription Required

Marketer

Chinar Therapeutics Pvt.&Ltd.

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitascore-M 500/50 Tablet

Duo-Met 500/50 tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like kidney failure and vision loss, potentially lowering heart attack and stroke risk. Duo-Met 500/50 may be used independently or with other diabetes treatments. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, including current health, blood sugar levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes efficacy; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is possible, especially with concurrent use of insulin or sulfonylureas; learn its recognition and management. This medication isn't for everyone. Inform your doctor of pre-existing kidney, liver, heart, or pancreatic conditions, or excessive alcohol consumption. Pregnant or breastfeeding individuals require medical consultation before use. Interactions with other medications are possible; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Sitascore-M 500/50 Tablet

No text provided. Please provide the text you want me to rephrase.

Uses of Sitascore-M 500/50 Tablet

Managing type 2 diabetes

Major Benefits of Sitascore-M 500/50 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sitascore-M 500/50 Tablet with a meal.

Common Side effects of Sitascore-M 500/50 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitascore-M 500/50 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Sitascore-M 500/50 Tablets should be administered with a meal.

How Sitascore-M 500/50 Tablet works:

Sitascore-M 500/50 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Sitascore-M 500/50 Tablets; doing so is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitascore-M 500/50 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitascore-M 500/50 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a possibility if your blood glucose level is either abnormally low or elevated. Refrain from driving should such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitascore-M 500/50 tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Sitascore-M 500/50 tablets. Physician consultation is advised. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Sitascore-M 500/50 tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitascore-M 500/50 Tablet :

Should you forget to take a Sitascore-M 500/50 Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitascore-M 500/50 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitascore-M 500/50 Tablet

Sitascore-M 500/50 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitascore-M 500/50 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues (including tingling, numbness in extremities, weakness, and balance problems), urinary difficulties, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Sitascore-M 500/50 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitascore-M 500/50 Tablets are contraindicated in patients with allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and Sitascore-M 500/50 Tablet is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (like Sitascore-M 500/50 Tablet) can rarely cause lactic acidosis (MALA), a serious medical emergency involving high blood lactic acid levels. This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Sitascore-M 500/50 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitascore-M 500/50 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Sitascore-M 500/50 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. This medication should also be avoided in individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitascore-M 500/50 Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (like Sitascore-M 500/50) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called Metformin-Associated Lactic Acidosis or MALA). This risk is higher in patients with kidney problems, older adults, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitascore-M 500/50 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitascore-M 500/50 Tablet combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitascore-M 500/50 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitascore-M 500/50 Tablets are contraindicated in patients with known allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitascore-M 500/50 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (like Sitascore-M 500/50) can rarely cause lactic acidosis, a serious medical emergency involving high blood lactic acid levels (also called MALA—Metformin-associated lactic acidosis). This risk is higher in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Sitascore-M 500/50 Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitascore-M 500/50 Tablet
149
MRP 173
13% off